526 related articles for article (PubMed ID: 23526406)
1. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
[TBL] [Abstract][Full Text] [Related]
2. Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas.
Kobayakawa M; Matsubara T; Mizokami A; Hiura F; Takakura N; Kokabu S; Matsuda M; Yasuda H; Nakamura I; Takei Y; Honda H; Hosokawa R; Jimi E
Cell Biochem Funct; 2020 Apr; 38(3):300-308. PubMed ID: 31887784
[TBL] [Abstract][Full Text] [Related]
3. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.
Vives V; Laurin M; Cres G; Larrousse P; Morichaud Z; Noel D; Côté JF; Blangy A
J Bone Miner Res; 2011 May; 26(5):1099-110. PubMed ID: 21542010
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling.
Uehara S; Udagawa N; Mukai H; Ishihara A; Maeda K; Yamashita T; Murakami K; Nishita M; Nakamura T; Kato S; Minami Y; Takahashi N; Kobayashi Y
Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851822
[TBL] [Abstract][Full Text] [Related]
5. The unique function of p130Cas in regulating the bone metabolism.
Jimi E; Honda H; Nakamura I
Pharmacol Ther; 2022 Feb; 230():107965. PubMed ID: 34391790
[TBL] [Abstract][Full Text] [Related]
6. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2.
Duong LT; Nakamura I; Lakkakorpi PT; Lipfert L; Bett AJ; Rodan GA
J Biol Chem; 2001 Mar; 276(10):7484-92. PubMed ID: 11102447
[TBL] [Abstract][Full Text] [Related]
8. IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complex.
Nakamura I; Kadono Y; Takayanagi H; Jimi E; Miyazaki T; Oda H; Nakamura K; Tanaka S; Rodan GA; Duong LT
J Immunol; 2002 May; 168(10):5103-9. PubMed ID: 11994463
[TBL] [Abstract][Full Text] [Related]
9. p130Cas-dependent actin remodelling regulates myogenic differentiation.
Kawauchi K; Tan WW; Araki K; Abu Bakar FB; Kim M; Fujita H; Hirata H; Sawada Y
Biochem J; 2012 Aug; 445(3):323-32. PubMed ID: 22587391
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of p130Cas and c-Cbl in adhesion-induced or macrophage colony-stimulating factor-mediated signaling pathways in prefusion osteoclasts.
Nakamura I; Rodan GA; Duong LT
Endocrinology; 2003 Nov; 144(11):4739-41. PubMed ID: 12959979
[TBL] [Abstract][Full Text] [Related]
12. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
14. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
[TBL] [Abstract][Full Text] [Related]
15. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J
Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577
[TBL] [Abstract][Full Text] [Related]
16. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
Duong LT; Rodan GA
Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033
[TBL] [Abstract][Full Text] [Related]
17. Vinculin regulates osteoclast function.
Fukunaga T; Zou W; Warren JT; Teitelbaum SL
J Biol Chem; 2014 May; 289(19):13554-64. PubMed ID: 24675074
[TBL] [Abstract][Full Text] [Related]
18. Methods to Investigate the Role of Rho GTPases in Osteoclast Function.
Morel A; Blangy A; Vives V
Methods Mol Biol; 2018; 1821():219-233. PubMed ID: 30062415
[TBL] [Abstract][Full Text] [Related]
19. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
[TBL] [Abstract][Full Text] [Related]
20. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
